Get the Stockscreener App
16.52
0.48%
-0.085
Ceribell Inc stock is traded at $16.52, with a volume of 79,506.
It is down -0.48% in the last 24 hours and up +11.02% over the past month.
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.
See More
Previous Close:
$16.60
Open:
$16.67
24h Volume:
79,506
Relative Volume:
0.28
Market Cap:
$569.98M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+3.19%
1M Performance:
+11.02%
6M Performance:
-40.04%
1Y Performance:
+0.00%
1-Day Range:
$16.26
$17.23
1-Week Range:
$15.55
$17.93
52-Week Range:
$10.01
$32.75
Ceribell Inc Stock (CBLL) Company Profile
Name
Ceribell Inc
Sector
Industry
Phone
(800) 436-0826
Address
360 N. PASTORIA AVENUE, SUNNYVALE
Compare CBLL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CBLL
Ceribell Inc
|
16.52 | 569.98M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
129.34 | 231.50B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.94 | 154.04B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
385.45 | 144.27B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
84.41 | 105.58B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
76.66 | 43.95B | 5.54B | 4.18B | 623.10M | 7.00 |
Ceribell Inc Stock (CBLL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-04-25 | Initiated | Ladenburg Thalmann | Buy |
| Nov-05-24 | Initiated | BofA Securities | Buy |
| Nov-05-24 | Initiated | Canaccord Genuity | Buy |
| Nov-05-24 | Initiated | JP Morgan | Overweight |
| Nov-05-24 | Initiated | TD Cowen | Buy |
| Nov-05-24 | Initiated | William Blair | Outperform |
View All
Ceribell Inc Stock (CBLL) Latest News
Ceribell stock holds $36 target amid US-China trade deal hopes - Investing.com Canada
US$30.75: That's What Analysts Think CeriBell, Inc. (NASDAQ:CBLL) Is Worth After Its Latest Results - Yahoo Finance
Wells Fargo & Company MN Takes $167,000 Position in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell, Inc. Earnings Call Highlights Growth and Challenges - TipRanks
FDA Clears Ceribell’s Clarity™ Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Ages 1 Year and Older - The Globe and Mail
AI in Clinics and Hospitals, Along with FDA Steps Signal Opportunity for Early Mover Advantages - The Globe and Mail
Ceribell, Inc.: A Strong Buy Amidst Promising Growth and Robust Fundamentals - TipRanks
CeriBell revenue jumps 42% to USD 20.5 million in Q1 2025 - Medical Buyer
MetLife Investment Management LLC Acquires Shares of 7,749 CeriBell (NASDAQ:CBLL) - Defense World
Barclays PLC Makes New Investment in CeriBell (NASDAQ:CBLL) - Defense World
Earnings call transcript: CeriBell Q1 2025 revenue jumps, stock rises 6.81% - Investing.com
Ceribell, Inc. Receives Buy Rating Amid Strong Revenue Growth and Financial Performance - TipRanks
CeriBell Q1 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: CeriBell Q1 2025 revenue jumps, stock rises 6.81% By Investing.com - Investing.com South Africa
Ceribell reports Q1 EPS (36c), consensus (46c) - TipRanks
Ceribell Reports First Quarter 2025 Financial Results - GlobeNewswire
CeriBell Inc (CBLL) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Growth Amid ... By GuruFocus - Investing.com Canada
CeriBell Inc expected to post a loss of 42 cents a shareEarnings Preview - TradingView
Invesco Ltd. Takes $252,000 Position in CeriBell (NASDAQ:CBLL) - Defense World
Legal & General Group Plc Takes Position in CeriBell (NASDAQ:CBLL) - Defense World
Head-To-Head Survey: CeriBell (NASDAQ:CBLL) and ADM Tronics Unlimited (OTCMKTS:ADMT) - Defense World
Analysts Set CeriBell (NASDAQ:CBLL) PT at $32.50 - Defense World
Ceribell Earns FedRAMP High Authorization for Its Point-of-Care EEG - Medical Product Outsourcing
41,900 Shares in CeriBell (NASDAQ:CBLL) Acquired by Renaissance Technologies LLC - Defense World
Ceribell to Participate in the Bank of America Securities 2025 Health Care Conference - The Manila Times
CeriBell, Inc. to Present at Bank of America Securities 2025 Health Care Conference on May 14, 2025 - Nasdaq
CeriBell Gets FedRAMP High Authorization for EEG System - marketscreener.com
Ceribell Says EEG System Receives FedRAMP High Authorization - marketscreener.com
Ceribell Receives FedRAMP® High Authorization, Expanding Approval for Its AI-Powered Point-of-Care EEG Across Federal Healthcare Systems - The Manila Times
Ceribell Receives FedRAMP® High Authorization, Expanding - GlobeNewswire
Ceribell announces EEG system received full RedRAMP High authorization - TipRanks
JPMorgan Chase & Co. Takes $880,000 Position in CeriBell (NASDAQ:CBLL) - Defense World
Geode Capital Management LLC Makes New $6.65 Million Investment in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell to Report First Quarter 2025 Financial Results on May 8, 2025 - The Manila Times
CeriBell, Inc. to Release Q1 2025 Financial Results and Host Conference Call on May 8, 2025 - Nasdaq
CBLL Stock Sees Surge of Approximately 3.50% in Last Five Days - knoxdaily.com
Ceribell Inc (CBLL) stock analysis: A comprehensive overview - uspostnews.com
CeriBell (NASDAQ:CBLL) Trading Down 2.9% on Insider Selling - Defense World
Ceribell's Retail Popularity Surges After Small-Cap Medtech Firm Assures No Tariff Impact Until Q4 - MSN
Alliancebernstein L.P. Invests $532,000 in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell wins FDA nod for algorithm to detect pediatric seizures - MedTech Dive
Ceribell, Inc.: Promising Growth Trajectory and Strong Market Potential Reinforce Buy Rating - TipRanks
Vanguard Group Inc. Takes $18.02 Million Position in CeriBell (NASDAQ:CBLL) - Defense World
CBLL Stock Falls Despite FDA Clearance for Pediatric Clarity Algorithm - MSN
Ceribell announces FDA grants clearance for next-gen Ceribell Clarity algorithm - TipRanks
CeriBell Says FDA Clears Electrographic Seizure Detection Algorithm - marketscreener.com
Ceribell Inc Stock (CBLL) Financials Data
There is no financial data for Ceribell Inc (CBLL). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Ceribell Inc Stock (CBLL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Chao Xingjuan | President and CEO |
Apr 22 '25 |
Sale |
15.06 |
300 |
4,518 |
742,779 |
2.44%
2.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):